BRPI0412681A - composição farmacêutica para a administração por via nasal de piribedil - Google Patents

composição farmacêutica para a administração por via nasal de piribedil

Info

Publication number
BRPI0412681A
BRPI0412681A BRPI0412681-5A BRPI0412681A BRPI0412681A BR PI0412681 A BRPI0412681 A BR PI0412681A BR PI0412681 A BRPI0412681 A BR PI0412681A BR PI0412681 A BRPI0412681 A BR PI0412681A
Authority
BR
Brazil
Prior art keywords
piribedil
pharmaceutical composition
nasal administration
nasal
administration
Prior art date
Application number
BRPI0412681-5A
Other languages
English (en)
Inventor
Herve Rolland
Patrick Wuthrich
Original Assignee
Servier Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Servier Lab filed Critical Servier Lab
Publication of BRPI0412681A publication Critical patent/BRPI0412681A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Otolaryngology (AREA)
  • Hospice & Palliative Care (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Psychiatry (AREA)
  • Psychology (AREA)
  • Cardiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

"COMPOSIçãO FARMACêUTICA PARA A ADMINISTRAçãO POR VIA NASAL DE PIRIBEDIL". A presente invenção refere-se a uma composição farmacêutica para a administração por via nasal de piribedil em solução ou sob a forma de pó.
BRPI0412681-5A 2003-07-17 2004-07-16 composição farmacêutica para a administração por via nasal de piribedil BRPI0412681A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0308712A FR2857594B1 (fr) 2003-07-17 2003-07-17 Composition pharmaceutique pour l'administration par voie nasale de piribedil
PCT/FR2004/001867 WO2005009442A1 (fr) 2003-07-17 2004-07-16 Composition pharmaceutique pour l’administration par voie nasale de piribedil

Publications (1)

Publication Number Publication Date
BRPI0412681A true BRPI0412681A (pt) 2006-10-03

Family

ID=33548200

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0412681-5A BRPI0412681A (pt) 2003-07-17 2004-07-16 composição farmacêutica para a administração por via nasal de piribedil

Country Status (29)

Country Link
US (1) US20060204449A1 (pt)
EP (1) EP1653963B1 (pt)
JP (1) JP2007516947A (pt)
KR (1) KR100807480B1 (pt)
CN (1) CN100540004C (pt)
AR (1) AR046808A1 (pt)
AT (1) ATE349213T1 (pt)
AU (1) AU2004258714A1 (pt)
BR (1) BRPI0412681A (pt)
CA (1) CA2532631C (pt)
CY (1) CY1106013T1 (pt)
DE (1) DE602004003955T2 (pt)
DK (1) DK1653963T3 (pt)
EA (1) EA011041B1 (pt)
ES (1) ES2279435T3 (pt)
FR (1) FR2857594B1 (pt)
GE (1) GEP20074259B (pt)
HR (1) HRP20070081T5 (pt)
MA (1) MA27864A1 (pt)
MX (1) MXPA06000641A (pt)
MY (1) MY137747A (pt)
NO (1) NO332776B1 (pt)
NZ (1) NZ544460A (pt)
PL (1) PL1653963T3 (pt)
PT (1) PT1653963E (pt)
SI (1) SI1653963T1 (pt)
UA (1) UA85193C2 (pt)
WO (1) WO2005009442A1 (pt)
ZA (1) ZA200600240B (pt)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2303330B2 (en) 2008-06-06 2021-06-16 Pharma Two B Ltd. Pharmaceutical compositions for treatment of parkinson's disease
US20160022572A1 (en) * 2013-03-13 2016-01-28 N To B Ltd. Methods, compositions and devices for treatment of motor and depression symptoms associated with parkinson's disease
IT201800005117A1 (it) * 2018-05-07 2019-11-07 Acqua irradiata con energie elettromagnetiche per uso terapeutico

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5756483A (en) * 1993-03-26 1998-05-26 Merkus; Franciscus W. H. M. Pharmaceutical compositions for intranasal administration of apomorphine
BE1007402A5 (nl) * 1993-03-26 1995-06-06 Adir Nasale farmaceutische preparaten met progestagene stof.
FR2710268B1 (fr) * 1993-09-22 1995-10-20 Adir Utilisation de beta-cyclodextrines partiellement méthylées comme promoteurs d'absorption dans la préparation de compositions pharmaceutiques pour l'administration transcutanée de principes actifs.
FR2710265B1 (fr) * 1993-09-22 1995-10-20 Adir Composition pharmaceutique bioadhésive pour la libération contrôlée de principes actifs.
FR2742989B1 (fr) * 1995-12-29 1998-01-23 Adir Composition pharmaceutique bioadhesive pour la liberation controlee de principes actifs
NZ501321A (en) * 1997-03-26 2001-04-27 Franciscus W Nasal Melatonin composition
EP0900567A3 (en) * 1997-09-05 2001-05-02 Pfizer Products Inc. Quinazoline-4-one AMPA antagonists for the treatment of dyskinesias associated with dopamine agonist therapy
US20020002175A1 (en) * 2000-09-19 2002-01-03 Charanjit Behl Nasal delivery of apomorphine in combination with glycol derivatives
US20040028613A1 (en) * 2001-06-25 2004-02-12 Nastech Pharmaceutical Company Inc Dopamine agonist formulations for enhanced central nervous system delivery
FR2827516B1 (fr) * 2001-07-19 2003-09-19 Servier Lab Composition pharmaceutique pour l'administration par voie nasale d'estradiol et de norethisterone

Also Published As

Publication number Publication date
DE602004003955T2 (de) 2007-12-06
PL1653963T3 (pl) 2007-02-28
GEP20074259B (en) 2007-12-10
EP1653963B1 (fr) 2006-12-27
MY137747A (en) 2009-03-31
HRP20070081T3 (hr) 2007-04-30
NZ544460A (en) 2008-04-30
WO2005009442A1 (fr) 2005-02-03
FR2857594A1 (fr) 2005-01-21
ES2279435T3 (es) 2007-08-16
MXPA06000641A (es) 2006-03-30
CA2532631A1 (fr) 2005-02-03
ATE349213T1 (de) 2007-01-15
DE602004003955D1 (de) 2007-02-08
NO332776B1 (no) 2013-01-14
CN1819828A (zh) 2006-08-16
HK1094153A1 (zh) 2007-03-23
SI1653963T1 (sl) 2007-04-30
PT1653963E (pt) 2007-02-28
DK1653963T3 (da) 2007-04-10
NO20060743L (no) 2006-02-16
ZA200600240B (en) 2007-03-28
US20060204449A1 (en) 2006-09-14
FR2857594B1 (fr) 2005-09-16
EP1653963A1 (fr) 2006-05-10
KR20060031689A (ko) 2006-04-12
EA200600172A1 (ru) 2006-06-30
CA2532631C (fr) 2011-01-04
EA011041B1 (ru) 2008-12-30
UA85193C2 (ru) 2009-01-12
CY1106013T1 (el) 2011-04-06
CN100540004C (zh) 2009-09-16
AR046808A1 (es) 2005-12-28
AU2004258714A1 (en) 2005-02-03
MA27864A1 (fr) 2006-04-03
HRP20070081T5 (hr) 2007-08-31
JP2007516947A (ja) 2007-06-28
KR100807480B1 (ko) 2008-02-25

Similar Documents

Publication Publication Date Title
CY1113003T1 (el) Ευσταθη παρασκευασματα laquinimod
AR071187A1 (es) Compuesto de arilmetil-tiazinamina, composicion farmaceutica que lo comprende y su uso para preparar un medicamento para el tratamiento de la enfermedad de alzheimer
EP1646276A4 (en) SPRAY FOR THE PRODUCTION OF A MEDICAMENT IN AEROSOL FORM
BRPI0518266A2 (pt) medicamento oral de libertaÇço modificada de pelo menos um princÍpio ativo sob a forma multimicrocapsular
EP1807146A4 (en) COMPOSITION TO IMPROVE THE EFFICIENCY OF THE MEDICINAL PRODUCT
MX2009004017A (es) Usos de los compuestos carboxi-amido triazol y sus sales.
CY1118179T1 (el) Φαρμακευτικη συνθεση
BRPI0407234A (pt) Heterociclos substituìdos
UA93709C2 (ru) 12-имидазолил-1-додеканол и его применение b изготовлении фармацевтических композиций
BRPI0513455A (pt) formulação para mascaramento de sabor compreendendo o fármaco em uma forma de dissolução retardada e/ou ciclodextrina em uma forma de dissolução melhorada
BRPI0816798A2 (pt) composto, composição farmacêutica, métodos para inibir a ação do glicogênio sintase cinase-3, e para tratar, prevenir ou melhorar uma doença, uso de um composto, e, artigo de fabricação
DE60336225D1 (de) Neue pharmazeutische zusammenstezungen, flibanserin polymorph a enthaltend
AR054129A1 (es) Derivados de 2, 6-quinolinilo, una preparacion farmaceutica que los contiene y su empleo en la fabricacion de medicamentos para el tratamiento de enfermedades dependientes de integrinas alfa4beta1 y/o alfa4beta7
PL1809288T3 (pl) Zastosowanie pochodnych 1,4-bis-(3-aminoalkilo)piperazyny do leczenia chorób neurodegeneracyjnych
BRPI0412364A (pt) composição farmacêutica sólida, compreendendo amisulpride
BRPI0412681A (pt) composição farmacêutica para a administração por via nasal de piribedil
TW200626149A (en) Tricycles, their manufacture and use as pharmaceutical agents
TW200626591A (en) Amide derivatives, their manufacture and use as pharmaceutical agents
UA10675S (uk) Упаковка фармацевтичного засобу «краплі в ніс»
UA9011S (uk) Упаковка фармацевтичного засобу «кетозорал»
MX2009004187A (es) Derivados de heterociclil piridil sulfonamida, su manufactura y uso como agentes farmaceuticos.
ITMI20021405A0 (it) Composizioni farmaceutiche per il trattamento di infezioni da patogeni dell'apparato respiratorio
UA10680S (uk) Упаковка фармацевтичного засобу «корвалол-новий-дарниця»
UA10863S (uk) Етикетка фармацевтичного засобу «корвалол-новий-дарниця»
UA10726S (uk) Комплект упаковок для фармацевтичного препарату «дермазол»

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B08L Patent application lapsed because of non payment of annual fee [chapter 8.12 patent gazette]

Free format text: REFERENTE AO NAO RECOLHIMENTO DAS 8A E 9A ANUIDADES.

B08I Publication cancelled [chapter 8.9 patent gazette]

Free format text: ANULADA A PUBLICACAO CODIGO 8.12 NA RPI NO 2259 DE 22/04/2014 POR TER SIDO INDEVIDA.

B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE AS 8A, 9A, 10A, 11A, 12A, 13A, 14A, 15A E 16A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2602 DE 17-11-2020 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.